NUXP.OB Insider Trading Activity and SEC Form 4 Filings
NUXP.OB insider trading summary
No open-market insider purchases or sales of Nurx Pharmaceuticals, Inc. (NUXP.OB) have been reported on SEC Form 4 in the past 12 months.
Latest NUXP.OB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 21, 2010 | Harin Padma-Nathan | Chief Executive Officer | Buy | $0 (2,777,778 @ $0.00) |
| Apr 21, 2010 | Sharyar Baradaran | Director | Buy | $0 (2,777,778 @ $0.00) |
| Oct 9, 2009 | Santa Monica Capital Partners II, LLC | 10% Owner | Sell | $100K (400,000 @ $0.25) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.